Study: Men looking to live longer should hit the sauna


A new study suggests that men who want to live longer should prepare to sweat it out in a Finnish sauna several times a week.
Researchers looked at 2,315 Finnish men who have had their health tracked since 1984, the Los Angeles Times reports. The participants were between 42 and 60, with a median age of 53, and those who visited a sauna two to three times a week had a 23 percent lower risk of having cardiovascular disease or coronary heart disease compared to those who went just once weekly. The benefits were even better for men who used the sauna four to seven times a week, with a 48 percent lower risk of similar incidents compared to those who went once a week.
Researchers wrote that they are not sure why saunas have such a health benefit, and further studies are needed. It's unlikely the same thing would happen in regular hot tub and steam rooms, researchers said, as Finnish saunas have dry air with 10 to 20 percent humidity and are kept at 176 to 212 degrees, causing heart rates to go up to 100 to 150 beats per minute and more blood flow to the skin and less to internal organs. "Previous studies have suggested that sauna bathing might have some harmful effects, whereas our results indicated a protective effect," the authors wrote.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Bombs or talks: What’s next in the US-Iran showdown?
Talking Points US gives Tehran a two month deadline to deal
By Joel Mathis, The Week US Published
-
Inside the contested birth years of generations
The Explainer Battles over where Gen Z ends and Gens Alpha and Beta begin remain unsettled
By David Faris Published
-
Art review: Jack Whitten: The Messenger
Feature Museum of Modern Art, New York City, through Aug. 2
By The Week US Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published